Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
Immobilized Human SIRP alphaV2 (31-148), Llama IgG2b Fc Tag (Cat. No. SI2-H5257) at 5 μg/mL (100 μL/well) can bind Human CD47, His Tag (Cat. No. CD7-H5227) with a linear range of 0.02-0.313 μg/mL (QC tested).
The purity of Human SIRP alphaV2, Llama IgG2b Fc Tag (Cat. No. SI2-H5255) is more than 90% and the molecular weight of this protein is around 130-160 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Relugolix/Estradiol/Norethindrone Acetate | E2/NETA | Approved | Myovant Sciences | MYFEMBREE, RYEQO | United States | Menorrhagia; Leiomyoma | Myovant Sciences | 2021-05-26 | Pain; Endometriosis; Leiomyoma; Menorrhagia; Uterine Neoplasms | Details |
Elagolix/estradiol/norethindrone acetate | Approved | Abbvie Inc | Oriahnn | United States | Menorrhagia | Abbvie Inc | 2020-05-29 | Menorrhagia | Details | |
Relugolix/Estradiol/Norethindrone Acetate | E2/NETA | Approved | Myovant Sciences | MYFEMBREE, RYEQO | United States | Menorrhagia; Leiomyoma | Myovant Sciences | 2021-05-26 | Pain; Endometriosis; Leiomyoma; Menorrhagia; Uterine Neoplasms | Details |
Elagolix/estradiol/norethindrone acetate | Approved | Abbvie Inc | Oriahnn | United States | Menorrhagia | Abbvie Inc | 2020-05-29 | Menorrhagia | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
IBC-0966 | IBC-0966 | Phase 2 Clinical | SunHo (China) BioPharmaceutical Co Ltd | Neoplasms | Details |
BI-765063 | OSE-172; BI-765063 | Phase 1 Clinical | Ose Immunotherapeutics | Solid tumours; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung | Details |
Anzurstobart | BMS-986351; CC-95251 | Phase 1 Clinical | Celgene Corp | Myelodysplastic Syndromes; Leukemia, Myeloid, Acute | Details |
ADU-1805 | ADU-1805 | Phase 1 Clinical | Aduro Biotech Inc | Solid tumours; Neoplasms; Neoplasm Metastasis | Details |
LM-101 | LM-101 | Phase 1 Clinical | LaNova Medicines Ltd | Leukemia; Solid tumours; Hematologic Neoplasms; Neoplasms | Details |
Q-1801 | Q-1801; Q 1801 | Phase 1 Clinical | Qiyu Biotechnology (Shanghai) Co Ltd | Solid tumours | Details |
Recombinant humanized IgG4 anti-SIRPα antibody(Daiichi Sankyo) | DS-1103a | Phase 1 Clinical | Daiichi Sankyo Co Ltd | Solid tumours; Breast Neoplasms | Details |
ELA-026 | ELA-026 | Phase 1 Clinical | Electra Therapeutics Inc | Lymphohistiocytosis, Hemophagocytic | Details |
BYON-4228 | BYON-4228 | Phase 1 Clinical | Byondis Bv | Solid tumours; Lymphoma | Details |
BSI-082 | BSI-082 | Phase 1 Clinical | Boaoxin Biotechnology(Nanjing) Co Ltd | Hematologic Neoplasms; Solid tumours | Details |
BR-105 | BR-105; BR105 | Phase 1 Clinical | BioRay Pharmaceutical Co Ltd | Neoplasms | Details |
[89Zr]Zr- BI-765063(Boehringer Ingelheim) | Phase 1 Clinical | Boehringer Ingelheim Corp | Squamous Cell Carcinoma of Head and Neck; Carcinoma, Non-Small-Cell Lung; Melanoma | Details | |
TQB-2928 | TQB-2928 | Phase 1 Clinical | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Hematologic Neoplasms; Solid tumours; Myelodysplastic Syndromes; Neoplasms; Leukemia, Myeloid, Acute | Details |
BI-765080 | Phase 1 Clinical | C.H. Boehringer Sohn Ag & Co. Kg | Details | ||
ES-004 | ES-004; ES 004-N4; ES 004-B4 | Phase 1 Clinical | Elpiscience (Shanghai) Biopharma Ltd | Solid tumours; Neoplasms | Details |
IBC-0966 | IBC-0966 | Phase 2 Clinical | SunHo (China) BioPharmaceutical Co Ltd | Neoplasms | Details |
BI-765063 | OSE-172; BI-765063 | Phase 1 Clinical | Ose Immunotherapeutics | Solid tumours; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung | Details |
Anzurstobart | BMS-986351; CC-95251 | Phase 1 Clinical | Celgene Corp | Myelodysplastic Syndromes; Leukemia, Myeloid, Acute | Details |
ADU-1805 | ADU-1805 | Phase 1 Clinical | Aduro Biotech Inc | Solid tumours; Neoplasms; Neoplasm Metastasis | Details |
LM-101 | LM-101 | Phase 1 Clinical | LaNova Medicines Ltd | Leukemia; Solid tumours; Hematologic Neoplasms; Neoplasms | Details |
Q-1801 | Q-1801; Q 1801 | Phase 1 Clinical | Qiyu Biotechnology (Shanghai) Co Ltd | Solid tumours | Details |
Recombinant humanized IgG4 anti-SIRPα antibody(Daiichi Sankyo) | DS-1103a | Phase 1 Clinical | Daiichi Sankyo Co Ltd | Solid tumours; Breast Neoplasms | Details |
ELA-026 | ELA-026 | Phase 1 Clinical | Electra Therapeutics Inc | Lymphohistiocytosis, Hemophagocytic | Details |
BYON-4228 | BYON-4228 | Phase 1 Clinical | Byondis Bv | Solid tumours; Lymphoma | Details |
BSI-082 | BSI-082 | Phase 1 Clinical | Boaoxin Biotechnology(Nanjing) Co Ltd | Hematologic Neoplasms; Solid tumours | Details |
BR-105 | BR-105; BR105 | Phase 1 Clinical | BioRay Pharmaceutical Co Ltd | Neoplasms | Details |
[89Zr]Zr- BI-765063(Boehringer Ingelheim) | Phase 1 Clinical | Boehringer Ingelheim Corp | Squamous Cell Carcinoma of Head and Neck; Carcinoma, Non-Small-Cell Lung; Melanoma | Details | |
TQB-2928 | TQB-2928 | Phase 1 Clinical | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Hematologic Neoplasms; Solid tumours; Myelodysplastic Syndromes; Neoplasms; Leukemia, Myeloid, Acute | Details |
BI-765080 | Phase 1 Clinical | C.H. Boehringer Sohn Ag & Co. Kg | Details | ||
ES-004 | ES-004; ES 004-N4; ES 004-B4 | Phase 1 Clinical | Elpiscience (Shanghai) Biopharma Ltd | Solid tumours; Neoplasms | Details |
This web search service is supported by Google Inc.